Mycenax Biotech Inc. (TPEX:4726)
Taiwan · Delayed Price · Currency is TWD 27.15
-0.15 (-0.55%)
May 29, 2026, 1:30 PM CST
Mycenax Biotech Market Cap
Mycenax Biotech has a market cap or net worth of 5.63 billion as of May 29, 2026. Its market cap has decreased by -18.13% in one year.
Market Cap
5.63B
Enterprise Value
6.59B
Revenue
815.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.15
Market Cap Chart
Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 5.63B, an increase of 863.25%. That is a compound annual growth rate of 13.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 5.63B | -14.07% |
| Dec 31, 2025 | 6.55B | -26.98% |
| Dec 31, 2024 | 8.97B | 22.00% |
| Dec 29, 2023 | 7.35B | -4.53% |
| Dec 30, 2022 | 7.70B | 32.48% |
| Dec 30, 2021 | 5.81B | 40.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiGen Biopharmaceuticals Holdings | 6.43B |
| Savior Lifetec | 5.88B |
| Sinphar Pharmaceutical | 5.80B |
| AnnJi Pharmaceutical | 5.54B |
| Panion & Bf Biotech | 5.19B |
| ACRO Biomedical | 5.02B |
| UnicoCell Biomed | 5.01B |
| Pharmosa Biopharm | 4.91B |